TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$25 Million

Transition Theraeputics

At-the-market Offering

Developer of therapeutics for disease indications. The company provides a product for the treatment of Alzheimer's disease and for the treatment of diabetes.